EHA 2026
By Buzzbox Media · Last reviewed August 3, 2026
What is EHA?
The European hematology flagship, 11,000+ hematologists annually, including a strong contingent from Asia and Latin America. Best venue for oncology and benign hematology products with European or global market goals.
What are the key facts about EHA?
- Host organization: European Hematology Association
- Primary specialty: hematology
- Scale: large
- Geography: International
- International attendance: ~75%
- See all Oncology conferences
Which device categories fit EHA?
Which buyer stages does EHA fit?
What does EHA charge for booth space?
Cost not published
European Hematology Association does not publish booth pricing for EHA that we can link to, so we do not list a figure here. We would rather show nothing than an estimate you cannot check. Ask them directly on the EHA exhibitor page ↗.
Planning the EHA booth itself? Read our guide to medical conference booth design for booth types, union labor rules, and the corner upgrade.
Who attends EHA?
Hematologists from 100+ countries. Strong academic component, late-breaking malignant and benign hematology research.
- Purchasing authority: ~35% of attendees
- Effective buyers: ~3,850
- International attendance: ~75%
Where is EHA held?
- Venue: Frankfurt, Germany (rotates across European cities)
- Management company: EHA (in-house)
- Product theater: Available
Who else exhibits at EHA?
Approximately 100+ exhibitors typically attend EHA. Your competitors are here.
Is EHA worth exhibiting?
Why Exhibit
The European hematology flagship, 11,000+ hematologists annually, including a strong contingent from Asia and Latin America. Best venue for oncology and benign hematology products with European or global market goals.
Why Skip
Skip if hematology is adjacent rather than core to your portfolio, the audience is highly specialized and won't engage with generic oncology messaging. Heavy academic skew (35% purchasing authority).
What should exhibitors know before EHA?
EHA satellite symposia book early and are oversubscribed. Cell and gene therapy companies dominate the latest editions. KOL programs around late-breaking abstracts drive the highest qualified-meeting volume.
What is the Buzzbox Score for EHA?
8.4 / 10 (Excellent)
8.4 out of 10. A top-tier show worth a serious line item. Carried by growth trajectory (8.8: large and well-established and 11,000 attendees). The lightest dimension is data transparency (7.6, ). The European hematology flagship, 11,000+ hematologists annually, including a strong contingent from Asia and Latin America.
How we score
Six weighted factors, each scored on a 0 to 100 rubric then normalized to a 7.0 to 10.0 band. Every show on this list cleared a relevance bar to be included, so 7.0 is the floor; the number tells you how far the leaders pull ahead. A factor we cannot source is left unscored rather than estimated, and the overall score above was set before any figure behind it was withdrawn.
Strong (8.0): 35% purchasing authority (clinician-heavy), 110:1 attendee-to-exhibitor ratio, and large-scale event.
Not scored on cost: this organizer publishes no booth price we can link to.
Solid (7.6): exhibitor count disclosed, and attendee purchasing-authority data published.
Strong (8.7): society-run exhibits (in-house), non-union venue (simpler, cheaper move-in), and product theater / demo stage available.
Strong (8.1): "who should skip" note included, the flagship / largest show in its niche, and product-theater opportunity for thought leadership.
Strong (8.8): large and well-established and 11,000 attendees.
When are the EHA exhibitor deadlines?
Detailed deadlines not yet published for EHA. Check the official site for the application window.
Frequently Asked Questions
How much does a booth cost at EHA?
EHA does not publish booth pricing we can link to, so we do not list a cost for this show. Rather than estimate one, we point you at the organizer's exhibitor page to request current rates directly.
How many people attend EHA?
EHA draws approximately 11,000 attendees. Hematologists from 100+ countries. Strong academic component, late-breaking malignant and benign hematology research.
How many EHA attendees have purchasing authority?
About 35% of EHA attendees hold purchasing authority, which works out to roughly 3,850 effective buyers out of approximately 11,000 attendees. Effective buyers multiplies total attendance by the share of attendees who hold purchasing authority. Both inputs are estimates drawn from organizer reporting and our own exhibitor research, so read the figure as directional rather than exact.
How does Buzzbox Media score EHA?
EHA carries a Buzzbox Score of 8.4 out of 10 (Excellent), with one caveat on this record: cost efficiency is not scored, because European Hematology Association publishes no booth price we can link to, and the overall score was set before that figure was withdrawn. The factors still scored are audience quality, data transparency, exhibitor experience, editorial value, and growth trajectory. Each factor is scored on a 0 to 100 rubric then normalized to a 7.0 to 10.0 band, and every conference in our index cleared a relevance bar to be listed, so 7.0 is the floor. On this record the highest is growth trajectory at 8.8 and the lowest is data transparency at 7.6.
When and where is EHA Congress 2026?
EHA Congress 2026 takes place June 11-14, 2026 in Frankfurt, Germany. The European Hematology Association rotates its annual congress among major European cities (Frankfurt, Madrid, Vienna, Stockholm), and the 2026 edition lands in Frankfurt. A virtual access option is also available for attendees who cannot travel.
How many people attend EHA Congress 2026?
EHA Congress 2026 is expected to draw approximately 11,000 hematologists from 100+ countries, making it the largest hematology-focused meeting in Europe. The audience has a strong academic component centered on late-breaking malignant and benign hematology research, with roughly 35% holding purchasing authority.
Who should exhibit at EHA Congress 2026?
EHA Congress 2026 is a strong fit for companies in hematology diagnostics, hematologic-oncology, transfusion medicine, cell and gene therapy, and digital health with European or global market goals. The audience is highly specialized, so generic oncology messaging underperforms. Cell and gene therapy companies have dominated recent editions, and KOL programs around late-breaking abstracts drive the most qualified meetings.
How do I book a booth or satellite symposium at EHA Congress 2026?
Exhibit and sponsorship inquiries for EHA Congress 2026 go through EHA Industry Relations (industry@ehaweb.org) via the official exhibition and sponsorship page at ehaweb.org. Satellite symposia book early and are routinely oversubscribed, so reach out well ahead of the June 2026 congress to secure placement.
Who exhibits at EHA Congress?
EHA exhibitors include companies selling oncology diagnostics, hematology analyzers, flow cytometry equipment, biologic and targeted therapy platforms, and laboratory reagents for leukemia, lymphoma, myeloma, and benign blood disorder research.
How does EHA compare to ASH for exhibitors?
EHA Congress draws 11,000 attendees versus ASH's 25,000+, but EHA's audience skews more toward European and international hematologists who are harder to reach at US-only events. For companies with global distribution, EHA provides complementary reach to ASH.